Contents

Brands and products limited online: Portugal market report

19th April 2019

Europe
Portugal
Market Research
Market reports

Looking at the online market in Portugal, we find that CBD online retail seems limited. Most of the sellers are head/growshops with previous connections to cannabis products, and most brands are international with ties to (non-CBD) cannabis products

Mexican legalisation may come with added regulation and controls

18th April 2019

Mexico
North America
Policy and Politics
Regulation and Legislation
Regulatory briefing

Mexico is well on its way to fully legalising cannabis and its derivative products, but the new government may impose stricter regulation than that left by the previous regime

Big Pharma ‘must not be allowed to set EU legal agenda on medical cannabis’

17th April 2019

EU
Europe
Policy and Politics
Public Health and Medicine
Regulation and Legislation
Regulatory briefing

Europe desperately needs harmonised legislation on medical cannabis – but it could take five years, and Big Pharma must not be allowed to set the agenda, delegates at a conference in Brussels heard

CBD not a controlled substance: Ireland regulatory report

17th April 2019

Europe
Ireland
Regulation and Legislation
Regulatory reports

In our look at the regulations governing CBD in Ireland, we find that cannabis, THC and CBN (cannabinol) are controlled substances  but CBD (cannabidiol) is not. Hemp may be grown under license and used for industrial purposes as long as EU regulations are observed

Regulatory tracker: current global regulation of CBD

17th April 2019

Afghanistan
Africa
Alabama
Alaska
Albania
Algeria
Andorra
Argentina
Arizona
Arkansas
Armenia
Armenia
Asia
Australasia
Australia
Austria
Bahrain
Bangladesh
Belarus
Belgium
Bosnia and Herzegovina
Brazil
Bulgaria
California
Cambodia
Canada
Chile
China
Colombia
Colorado
Connecticut
Croatia
Cyprus
Czech Republic
Delaware
Democratic Rep. of the Congo
Denmark
Ecuador
Egypt
England
Estonia
Ethiopia
EU
Europe
Finland
Florida
France
Georgia
Georgia
Germany
Greece
Hawaii
Honduras
Hong Kong
Hungary
Iceland
Idaho
Illinois
India
Indiana
Indonesia
Iowa
Iran
Iraq
Ireland
Isle of Man
Israel
Italy
Japan
Kansas
Kazakhstan
Kentucky
Kenya
Kosovo
Kuwait
Kyrgyzstan
Latvia
Libya
Lithuania
Louisiana
Luxemburg
Macedonia
Maine
Malaysia
Malta
Maryland
Massachusetts
Mauritania
Mexico
Michigan
Middle East
Minnesota
Mississippi
Missouri
Moldova
Monaco
Montana
Montenegro
Morocco
Mozambique
Myanmar
Namibia
Nebraska
Nepal
Netherlands
Nevada
New Hampshire
New Jersey
New Mexico
New York
New Zealand
Nigeria
North America
North Carolina
North Dakota
North Korea
Northern Ireland
Norway
Ohio
Oklahoma
Oman
Oregon
Pakistan
Pennsylvania
Peru
Philippines
Poland
Portugal
Qatar
Rhode Island
Romania
Russia
San Marino
Saudi Arabia
Scandinavia
Scotland
Serbia
Singapore
Slovakia
Slovenia
South Africa
South America
South Carolina
South Dakota
South Korea
Spain
Sri Lanka
Sudan
Sweden
Switzerland
Syria
Taiwan
Tanzania
Tennessee
Texas
Thailand
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
United Kingdom
United States
Uruguay
Utah
Uzbekistan
Vatican City
Venezuela
Vermont
Vietnam
Virginia
Wales
Washington
Washington D.C.
West Virginia
Wisconsin
World
Wyoming
Yemen
Zimbabwe
Marketing and Retailing
Policy and Politics
Public Health and Medicine
Regulation and Legislation
Regulatory trackers

Use the tabs at the top of the map to select a specific regulatory field. Clicking on an individual country will bring up much more detail in the panel below, including links to legislation and CBD-Intel coverage of that market.   Additions for April 2019: New countries added: Israel and Colombia Mexico: COFEPRIS revokes its […]

US attorney general favours bid to let states decide cannabis and CBD policy

16th April 2019

North America
United States
Policy and Politics
Regulation and Legislation
Regulatory briefing

US attorney general William Barr has said the current patchwork regulatory situation for CBD in the country is “intolerable” and given qualified support to an act which would allow states to decide their own policies

Social difficulties – how the big networks get in a tangle over CBD

15th April 2019

Europe
North America
United Kingdom
United States
Companies
Marketing and Retailing
Business briefing

CBD’s association with cannabis, on one level part of its marketing strength, can also be a big barrier to its acceptance. The major social networks all have as yet a rather ambiguous attitude

Spain clears up the confusion by clamping down on CBD novel foods

11th April 2019

EU
Europe
Spain
Regulation and Legislation
Regulatory briefing

The Spanish Agency for Consumption, Food Safety and Nutrition (AECOSAN) has issued a notice on hemp and cannabinoid use in foods, clarifying its position on European novel food regulations

European Commission differentiates CBD as cosmetic ingredient

10th April 2019

EU
Europe
Regulation and Legislation
Regulatory briefing

CBD’s entry in the European Commission’s database of cosmetics ingredients has been expanded to differentiate it from generic cannabis and by-products. The move offers more, but not total, clarity

Swedish firms rein in dietary sales and health claims until courts decide

9th April 2019

Europe
Sweden
Companies
Marketing and Retailing
Regulation and Legislation
Business briefing

Several Swedish companies offering dietary supplements with CBD oil produced from industrial hemp have either stopped selling the products or significantly toned down promises of its health benefits

Questions in UK parliament after medical cannabis is seized at airport

9th April 2019

Europe
United Kingdom
Policy and Politics
Public Health and Medicine
Regulation and Legislation
Regulatory briefing

Just two out of around 80 people prescribed medical cannabis in the UK have received products containing THC, with the rest getting CBD, the British parliament has heard

Top CBD brands tracker: Italy Q1 2019

9th April 2019

Asia
Australasia
Australia
Europe
Italy
New Zealand
North America
South America
World
Market Research
Marketing and Retailing
Pricing trackers

Welcome to the CBD-Intel online data tracker; here you can find a downloadable Excel database optimised for Mac or Windows software versions. The two versions exist because of differing functionalities between software versions; the Windows iteration is the optimal version.
The data within is from France, Germany, Italy, Netherlands and the UK, with pricing information covering brands selling CBD concentrates, edibles, e-liquid, flowers, oil, and topicals.

Federal assistance proposed for US CBD businesses with banking issues

5th April 2019

North America
United States
Regulation and Legislation
Regulatory briefing

Proposed new federal legislation in the US could finally help CBD businesses gain easier access to banking, a problem that has bedevilled legal cannabis-related industries since their inception.

US Postal Service offers guidance on mail delivery of CBD products

4th April 2019

North America
United States
Marketing and Retailing
Policy and Politics
Regulation and Legislation
Business briefing

Use of the federal mail to deliver CBD products has remained a vexed question for companies in the US since the passing of the 2018 Farm Bill. Now the US Postal Service has shone some light on the issue

FDA wades in with guidance on CBD – and warnings over ‘deceptive’ claims

3rd April 2019

North America
United States
Regulation and Legislation
Regulatory briefing

A high-level working group will explore legal pathways to market for certain CBD products, according to the US FDA – which also revealed it had sent warning letters to three companies it accused of “unfounded claims”

Ohio Senate passes bill to establish CBD market, as Texas delists hemp

3rd April 2019

Michigan
North America
Ohio
Texas
United States
Policy and Politics
Regulation and Legislation
Regulatory briefing

Ohio is moving a step nearer following its neighbour Michigan in distinguishing hemp-derived CBD products from state cannabis regulations, while Texas is to remove hemp from its list of controlled substances

Growing cannabis permitted under licence: Colombia regulatory report

2nd April 2019

Colombia
South America
Regulation and Legislation
Regulatory reports

In our latest look at South America, we find that in Colombia importing seeds for growing cannabis, or cannabis by-products, is only permitted under licence. CBD final products are allowed if they are within the legal limits (THC below 1%) while CBD e-liquids should, in principle, legal

Mexican regulatory body repeals guidelines amid confusion

29th March 2019

Mexico
North America
Regulation and Legislation
Regulatory briefing

The Mexican Federal Commission for the Protection Against Sanitary Risk (COFEPRIS) has changed its mind over the regulatory framework established for cannabis products in late 2018

Mainstream US drugstore chains announce plans to sell CBD

29th March 2019

Alabama
California
Colorado
Illinois
Indiana
Kentucky
Maryland
New Mexico
North America
Oregon
South Carolina
Tennessee
United States
Vermont
Companies
Marketing and Retailing
Policy and Politics
Public Health and Medicine
Business briefing

CBD products appears to be entering the mainstream of US retail. One of the largest retail pharmacy chains in the US, CVS is already selling a range of products in at least eight US states and Walgreens has announced plans to sell the product in nine states.

Philippines moves one step closer to legalising medical cannabis

29th March 2019

Asia
Philippines
Policy and Politics
Public Health and Medicine
Regulation and Legislation
Regulatory briefing

The Philippines moved one step closer to legalising cannabis for medical use when a bill was approved on its final reading, but its progress to law could be scuppered by opposition from president Rodrigo Duterte.

Leading UK specialist calls for medical cannabis trials – NICE says yes

28th March 2019

Europe
United Kingdom
Policy and Politics
Regulation and Legislation
Regulatory briefing

The UK’s National Institute for Health and Care Excellence (NICE) promises trials of medical cannabis after a senior consultant told a parliamentary committee of his worries about it being widely prescribed

Cannabis troubles – UK committee hears of inconsistency and confusion

26th March 2019

United Kingdom
Policy and Politics
Public Health and Medicine
Regulation and Legislation
Regulatory briefing

Inconsistent quality of products purchased online, and confusion over cannabis itself, could be putting patients at risk, a group of UK MPs were told during presentations on medical cannabis and related issues

Cannabis is popular left, right and centre as Israeli election approaches

22nd March 2019

Asia
Israel
Policy and Politics
Regulation and Legislation
Regulatory briefing

Politicians in Israel are rarely united on any single issue, but as the much contended Israeli election draws nearer, members from across the political spectrum support the full legalisation of recreational cannabis